Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Background and Design of a 5-Year St Elevation Myocardial Infarction Cohort in Isfahan, Iran: Semi-Ci Study Publisher



Sadeghi M1 ; Soleimani A2 ; Sarrafzadegan N3 ; Askari M4 ; Nouri F3 ; Masoumi G4 ; Hassannejad R3 ; Roohafza H3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Heart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Interventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

Source: ARYA Atherosclerosis Published:2022


Abstract

BACKGROUND: Cardiovascular disease (CVD) is one of the most important causes of mortality and morbidity in Iran. Secondary prevention of acute myocardial infarction (AMI) is necessary. The main aim of this cohort is evaluating clinical, paraclinical, management, and 5-year major events of the participants in Isfahan, Iran. METHODS: All consecutive patients with AMI hospitalized in Chamran Hospital, Isfahan, during 1 year from march 2015 were recruited and followed for 5 years. ST-Elevation Myocardial Infarction Cohort Study (SEMI-CI) has been initiated as a longitudinal study to evaluate course of patients with AMI in Iran, adherence to evidence-based secondary prevention drug, and five-year events such as death, re-myocardial infarction (REMI), re-hospitalization, congestive heart failure (CHF), and referring to another procedure [percutaneous coronary intervention (PCI), coronary artery bypass graft (CABG), and resynchronization therapy]. RESULTS: A total of 867 patients with ST-elevation myocardial infarction (STEMI) with mean age of 60.91 ± 12.76 years were recruited. 705 (81.3%) subjects were men with mean age of 59.63 ± 12.59 years. 470 (54.2%) patients had anterior AMI (ant-AMI) and the rest had other types of AMI. The ejection fraction (EF) mean was 37.80 ± 11.74 percent. A total of 30 (3.5%) cases of AMI had not received reperfusion. 445 (51.4%) had primary PCI and 392 (45.2%) had thrombolysis at first revascularization strategy. In-hospital death occurred in 72 participants (8.3%). Drug during hospital included: at discharge, 767 (88.5%) received aspirin, 787 (90.7%) statin, 697 (80.4%) beta-blocker, and 480 (55.4%) angiotensin-converting enzyme (ACE) inhibitor. CONCLUSION: According to the best of our knowledge, it is among few cohorts in Eastern Mediterranean Region (EMR) in patients with AMI. This paper showed methodology of this study in patients with STEMI and its follow-up protocol. We can use this result in policy-making for improving secondary prevention strategies. © 2022, Isfahan University of Medical Sciences(IUMS). All rights reserved.
Related Docs
View other Related Docs
1. Clinical Characteristics, Management and 1-Year Outcomes of Patients With Acute Coronary Syndrome in Iran: The Iranian Project for Assessment of Coronary Events 2 (Ipace2), BMJ Open (2015)
2. The Pragmatic Role of Covid-19 on the Thrombus Grade of Patients With Contemporary St-Segment-Elevation Myocardial Infarction, Journal of Tehran University Heart Center (2022)
3. Predictors of Mortality for Patients With St-Elevation Myocardial Infraction After 2-Year Follow-Up: A St-Elevation Myocardial Infarction Cohort in Isfahan Study, Advanced Biomedical Research (2022)
4. Availability and Nature of Cardiac Rehabilitation by Province in Iran: A 2018 Update of Iccpr's Global Audit, Journal of Research in Medical Sciences (2023)
5. Fixed Dose Combination Therapy for Secondary Prevention of Major Cardiovascular Events: Review of Literature and Design for Persian Polypill, a Randomized Clinical Trial, Current Problems in Cardiology (2022)
6. Explaining the Decline in Coronary Heart Disease Mortality Rate Using Impact Model: Estimation of the Changes in Risk Factors and Treatment Uptake in Iran Between 2007 and 2016, ARYA Atherosclerosis (2023)
7. Immediate Results and Six-Month Outcomes After Percutaneous Coronary Intervention in a Referral Heart Center in Isfahan, Iran, ARYA Atherosclerosis (2011)
8. Care of Patients With St-Elevation Myocardial Infarction: An International Analysis of Quality Indicators in the Acute Coronary Syndrome Stemi Registry of the Eurobservational Research Programme and Acvc and Eapci Associations of the European Society of Cardiology in 11 462 Patients, European Heart Journal: Acute Cardiovascular Care (2023)
Experts (# of related papers)
View all Related Experts
Nizal Sarrafzadegan (101)
Masoumeh Sadeghi (88)
Other Related Docs
9. Survey of Coronary Catheterization Laboratory Activity in Iran During the Coronavirus Disease-2019 Pandemic, ARYA Atherosclerosis (2021)
10. Medical Therapy Versus Percutaneous Coronary Intervention or Coronary Artery Bypass Graft in Stable Coronary Artery Disease; a Systematic Review and Meta-Analysis of Randomized Clinical Trials, ARYA Atherosclerosis (2022)
11. Methods of Sampling and Sample Size Determination of a Comprehensive Integrated Community-Based Interventional Trial: Isfahan Healthy Heart Program, ARYA Atherosclerosis (2018)
12. Design and Methodology of Heart Failure Registry: Results of the Persian Registry of Cardiovascular Disease, ARYA Atherosclerosis (2019)
13. Predictive Factors of Short-Term Survival From Acute Myocardial Infarction in Early and Late Patients in Isfahan and Najafabad, Iran, ARYA Atherosclerosis (2016)
14. Development of the First Iranian Clinical Practice Guidelines for the Diagnosis, Treatment, and Secondary Prevention of Acute Coronary Syndrome, Journal of Research in Medical Sciences (2024)
15. Analysis of Traditional Risk Factors on St-Segment Elevation Myocardial Infarction Characteristics; [بررسی عوامل خطر سنتی مرتبط با ویژگیهای بالینی بیماران انفارکتوس میوکارد با بالارونده قطعه St], Journal of Isfahan Medical School (2024)
16. Heart Rate and Cardiovascular Events: A Nested Case-Control in Isfahan Cohort Study, Archives of Iranian Medicine (2014)
17. The Comparison of Procedural and Clinical Outcomes of Thrombolytic-Facilitated and Primary Percutaneous Coronary Intervention in Patients With Acute St-Elevation Myocardial Infarction (Stemi): Findings From Prove/Acs Study, ARYA Atherosclerosis (2020)
18. Reperfusion Therapies and In-Hospital Outcomes for St-Elevation Myocardial Infarction in Europe: The Acvc-Eapci Eorp Stemi Registry of the European Society of Cardiology, European Heart Journal (2021)
19. The Pattern of In-Hospital Mortality of Myocardial Infarction and Associated Factors in Iran: A National Study, Journal of Isfahan Medical School (2015)
20. Persian Registry of Cardiovascular Disease (Prove): Design and Methodology, ARYA Atherosclerosis (2017)
21. Priority Setting in Cardiovascular Research in Iran Using Standard Indigenous Methods, Journal of Research in Medical Sciences (2022)
22. Cardiovascular Mortality in a Western Asian Country: Results From the Iran Cohort Consortium, BMJ Open (2018)
23. Longitudinal Association of Dietary Habits and the Risk of Cardiovascular Disease Among Iranian Population Between 2001 and 2013: The Isfahan Cohort Study, Scientific Reports (2023)
24. Effectiveness of Polypill for Primary and Secondary Prevention of Cardiovascular Diseases (Polyiran): A Pragmatic, Cluster-Randomised Trial, The Lancet (2019)
25. Temporal Trends of the Incidence of Ischemic Heart Disease in Iran Over 15 Years: A Comprehensive Report From a Multi-Centric Hospital-Based Registry, Clinical Epidemiology (2020)
26. Developing Non-Laboratory Cardiovascular Risk Assessment Charts and Validating Laboratory and Non-Laboratory-Based Models, Global Heart (2021)
27. Effectiveness of Tenecteplase Versus Streptokinase in Treatment of Acute Myocardial Infarction: A Meta-Analysis, Tehran University Medical Journal (2018)
28. Trends of 28 Days Case Fatality Rate After First Acute Myocardial Infarction in Isfahan, Iran, From 2000 to 2009, ARYA Atherosclerosis (2015)
29. Correaltion of Thrombolysis in Myocardial Infarction Risk Score and Angiographic Score in Patients With St-Elevation in Myocardial Infarction, Journal of Isfahan Medical School (2009)
30. Determination of Shock Index and Age Shock Index Cut-Off Points in Patients With St-Segment Elevation Myocardial Infarction: Semi-Ci Study, International Journal of Cardiovascular Sciences (2024)
31. Blood Group Types and Clinical, Procedural, and Adverse Outcomes in St-Elevated Myocardial Infarction Patients: A 3-Year Cohort in Iran, Journal of Research in Medical Sciences (2023)
32. Risk Factor Profile and Outcomes of Premature Acute Coronary Syndrome After Percutaneous Coronary Intervention: A 1-Year Prospective Design, Clinical Cardiology (2024)
33. Audit and Quality Assessment of National Persian Registry of Cardiovascular Disease(N-Prove) in Terms of Comorbidities, Angiography, and Angioplasty Characteristics in Iran, ARYA Atherosclerosis (2024)
34. Impact of Metabolic Syndrome on Ischemic Heart Disease - a Prospective Cohort Study in an Iranian Adult Population: Isfahan Cohort Study, Nutrition, Metabolism and Cardiovascular Diseases (2012)
35. Non-Administration of Thrombolytic Agents in Acute Myocardial Infarction Patients in Hajar Hospital, Shahrekord, Iran: Prevalence Rate and Causes, ARYA Atherosclerosis (2013)
36. Long-Term Hospital Readmission After St-Elevation Myocardial Infarction: A 3-Year Follow-Up From the Semi-Ci Study, Journal of Tehran University Heart Center (2022)
37. The Assessment of No-Reflow Phenomenon Incidence in Early Versus Delayed Percutaneous Coronary Intervention Following a Primary Fibrinolysis, ARYA Atherosclerosis (2024)
38. Determination of Characteristics and Data Elements Requirements in National Acute Coronary Syndrome Registries for Postdischarge Follow-Up, Current Problems in Cardiology (2023)
39. Use of Cardiovascular Disease Secondary Prevention Medications in Four Middle East Countries in a Community Setting, Global Heart (2024)
40. Current Status of the Clinical Epidemiology of Myocardial Infarction in Men and Women: A National Cross-Sectional Study in Iran, International Journal of Preventive Medicine (2015)
41. Differences Between the Characteristics of Ihd Patients Undergoing Different Treatment Modalities Who Adhere to Cardiac Rehabilitation Programs, Iranian Heart Journal (2014)
42. Factors Affecting Outcome of Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction, ARYA Atherosclerosis (2013)
43. The Effects of Comprehensive Home-Based Cardiac Rehabilitation Versus Usual Care in Patients With Ischemic Heart Disease in Iran: Study Protocol for a Multicenter Randomized Controlled Trial, International Journal of Preventive Medicine (2022)
44. Secular Trends in Cardiovascular Mortality in Iran, With Special Reference to Isfahan, Acta Cardiologica (1999)
45. Comparison of Survival Rate and Complications of Percutaneous Coronary Intervention, Coronary Artery Bypass Graft, and Medical Treatment in Patients With Left Main And/Or Three Vessel Diseases, ARYA Atherosclerosis (2020)
46. How Effective Are Strategies for Non-Communicable Disease Prevention and Control in a High Risk Population in a Developing Country? Isfahan Healthy Heart Programme, Archives of Medical Science (2010)
47. Is Cardiac Rehabilitation After Pci As Effective As Cabg? the First Experience From the Eastern Mediterranean Region Cardiac Rehabilitation Registry, ARYA Atherosclerosis (2024)
48. Isfahan Healthy Heart Program, Sample Size and Sampling Structure: A Comprehensive Report, Journal of Isfahan Medical School (2016)
49. A Review of Fixed-Dose Combination Therapy for Secondary Prevention of Adverse Cardiovascular Events and the Preliminary Results of the Persianpolypill Randomized Clinical Trial; [کارآزمایی بالینی تصادفی Persianpolypill شدهی مروری بر درمان ترکیبی با دوز ثابت برای پیشگیری ثانویه از حوادث نامطلوب قلبی- عروقی و نتایج اولیهی], Journal of Isfahan Medical School (2024)
50. A Cardiovascular Risk Assessment Model According to Behavioral, Psychosocial and Traditional Factors in Patients With St-Segment Elevation Myocardial Infarction (Cras-Mi): Review of Literature and Methodology of a Multi-Center Cohort Study, Current Problems in Cardiology (2023)